Target intelligence / Profile preview

Synaptogenesis

Molecular classification
Biological process
01

Overview

Synaptogenesis is the complex biological process by which neurons form new functional connections, known as synapses, within the nervous system (NIH, 2023). This process is most prolific during embryonic and early postnatal development but remains a critical mechanism for synaptic plasticity, learning, and memory throughout adulthood (PubMed, 2021). It involves the coordinated recruitment of presynaptic vesicles and the assembly of postsynaptic receptors, facilitated by cell adhesion molecules like neuroligins and neurexins (StatPearls, 2023). Dysregulation or failure of synaptogenesis is a primary pathological feature in neurodevelopmental disorders like autism and schizophrenia, while the progressive loss of synapses is the most significant correlate of cognitive decline in neurodegenerative diseases such as Alzheimer's disease (NIH, 2022). Although synaptogenesis is a physiological process rather than a single molecular target, it is a major therapeutic objective in drug discovery; compounds like ketamine and neurotrophic factors are frequently evaluated for their ability to promote synaptic density and restore functional neural circuits (PubMed, 2020).

Other names
Synapse formationSynaptic developmentSynaptogenySynaptic assembly
02

Mechanism of action

Modulation of synaptogenesis involves the induction of dendritic spine growth, recruitment of synaptic proteins (e.g., PSD-95, Synaptophysin), and activation of neurotrophic signaling pathways such as the BDNF/TrkB axis.

03

Biological functions

NeurodevelopmentSynaptic plasticityLearning and memoryNeural circuit formationCognitive function
04

Disease associations

Alzheimer's diseaseAutism spectrum disorderSchizophreniaMajor depressive disorderTraumatic brain injuryFragile X syndrome
05

Safety considerations

Risk of aberrant neural connectivityEpileptogenesis (due to hyper-excitability)ExcitotoxicityDevelopmental neurotoxicity if modulated during critical windows
06

Interacting drugs

Ketamine

5 more in the full profile.

07

Biomarkers

Synaptic vesicle protein 2A (SV2A) PET imagingSynaptophysin levelsPostsynaptic density protein 95 (PSD-95) levelsGrowth associated protein 43 (GAP-43)Neurogranin (CSF biomarker)

Beyond the preview

Go deeper on Synaptogenesis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptogenesis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call